Skip to main content

Israel’s parliament has unanimously approved a law to permit exports of medical marijuana, allowing Israel to tap the lucrative global market.

Israel will become the third country, after the Netherlands and Canada, to take its medical cannabis global.

The Israeli medical cannabis company iCAN predicts the global industry will reach US$33-billion in the next five years, as stigma fades and demand grows for the few countries certified to export.

Story continues below advertisement

The law was approved late Tuesday, sending cannabis company shares rising by about 10 per cent.

The law was stalled for years over fears from security officials that medical marijuana would leak into the black market. To assuage concerns, the law empowers police to supervise licensing.

The Israeli Cabinet must give final approval – a step seen as a formality.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter